Grifols (GIFLF) Asset Utilization Ratio (2011 - 2025)
Grifols' (GIFLF) quarterly Asset Utilization Ratio came in at 0.72 in Q4 2025, up 78.14% on a YoY basis from 0.41 in Q4 2024, and up 78.14% quarter-over-quarter from 0.41 in Q4 2024.
Powered by 
Analysis
Grifols (GIFLF) Asset Utilization Ratio (2011 - 2025) Analysis & Trends
Grifols (GIFLF) has reported Asset Utilization Ratio for 13 consecutive years, with 0.72 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Asset Utilization Ratio rose 78.14% year-over-year to 0.72; the trailing twelve-month figure through Dec 2025 stood at 0.72 (up 78.14% YoY), and the FY2025 full-year result was 0.76, down 45.88% from the prior year.
- Asset Utilization Ratio climbed to 0.72 in Q4 2025 per GIFLF's latest filing, from 0.41 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.72 in Q4 2025 and bottomed at 0.41 in Q4 2024.
- Historically, Asset Utilization Ratio has averaged 0.52 across 3 years, with a median of 0.42 in 2021.
- The sharpest annual moves came in 2021 and 2025: Asset Utilization Ratio grew 12.05% in 2021, then jumped 78.14% in 2025.
- Over 3 years, Asset Utilization Ratio stood at 0.42 in 2021, then decreased by 4.56% to 0.41 in 2024, then jumped by 78.14% to 0.72 in 2025.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.72, 0.41, and 0.42 for Q4 2025, Q4 2024, and Q4 2021 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | 0.40 |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | 0.47 |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | 0.38 |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | - |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | 0.20 |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | 0.90 |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | 0.33 |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | 0.00 |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | 0.72 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 0.72 |
| Dec 31, 2024 | 0.41 |
| Dec 31, 2021 | 0.42 |
| Dec 31, 2020 | 0.38 |
| Mar 31, 2020 | 0.61 |
| Dec 31, 2019 | 0.64 |
| Mar 31, 2019 | 0.52 |
| Dec 31, 2018 | 0.55 |
| Sep 30, 2018 | 0.56 |
| Jun 30, 2018 | 0.51 |
| Mar 31, 2018 | 0.51 |
| Dec 31, 2017 | 0.66 |
| Dec 31, 2016 | 0.50 |
| Sep 30, 2016 | 0.42 |
| Jun 30, 2016 | 0.42 |
| Mar 31, 2016 | 0.42 |
| Dec 31, 2015 | 0.42 |
| Mar 31, 2015 | 0.49 |
| Dec 31, 2014 | 0.49 |
| Sep 30, 2014 | 0.21 |